Uncommon complication of pulmonary arterial hypertension treatment with the parenteral use of treprostinil

Kardiol Pol. 2021 Jan 25;79(1):79-80. doi: 10.33963/KP.15672. Epub 2020 Nov 4.
No abstract available

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Epoprostenol / analogs & derivatives
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Hypertension, Pulmonary* / etiology
  • Pulmonary Arterial Hypertension*

Substances

  • Antihypertensive Agents
  • Epoprostenol
  • treprostinil